您的位置:网站名称 研发专利新闻 正文
内容搜索
热门内容
推荐内容
最新内容
反馈意见和建议

U.S. District Court rules in favor of Watson in generic SEASONIQUE patent infringement suit


Watson Pharmaceuticals, Inc. (NYSE: WPI), a leading integrated global pharmaceutical company, today confirmed that it has received a favorable decision from the U.S. Court of Appeals for the Federal Circuit related to its ongoing...

查看所有的文章内容需要 VIP会员权限 查看


 
点这里复制本页地址发送给您QQ/MSN上的好友

相关文章

US District Court rules against Watson i
USPTO issues Notice of Allowance to Alph
VARI, Gentel Biosciences receive U.S. Pa
Colorcon announces specific details on i
ACT to be awarded broad patent protectio
NephRx receives new U.S. patent for NX00
USPTO grants patent to ULURU's Altrazeal
NephRx receives new U.S. patent for NX00
PRWP receives two new patents for Galect
POZEN files motion for Treximet patent l
Biotectix acquires Chameleon BioSurfaces
USPTO issues Notice of Allowance to Modu
USPTO issues patent to Somaxon's Silenor
USPTO grants composition-of-matter paten
USPTO issues patent to Asterand's BioMAP
Medical industry veteran set to play key
Cubist enters license agreement with Tev
Shire files lawsuit against Watson over
USPTO issues notice of allowance to Mirn
EPO Board of Appeal rejects B.Braun pate

相关评论


本文章所属分类:首页 研发专利新闻